DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 1d ago
1TECN logo

Tecan Group AGBIT:1TECN Stock Report

Market Cap €2.6b
Updated 1d ago
Share Price
n/a
1Y25.7%
7D-0.9%
1D-0.8%
Portfolio Value
​
View

Tecan Group AG

BIT:1TECN Stock Report

Market Cap: €2.6b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Tecan Group (1TECN) Stock Overview

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. More details

1TECN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 41.7% below our estimate of its fair value

Earnings are forecast to grow 49.83% per year

Trading at good value compared to peers and industry

Risk Analysis

Volatile share price over the past 3 months compared to the Italian market


1TECN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW437,476 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
437,476 investors already sharing narratives
€
Current Price
€207.4044.0% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-116m1b2016201920222025202620282031Revenue CHF 1.1bEarnings CHF 148.6m
Advanced
View all narratives

Tecan Group AG Competitors

Fine Foods & Pharmaceuticals N.T.M

Symbol: BIT:FF
Market cap: €165.6m

AbCellera Biologics

Symbol: NasdaqGS:ABCL
Market cap: US$3.6b

Recordati Industria Chimica e Farmaceutica

Symbol: BIT:REC
Market cap: €10.7b

MGI Tech

Symbol: SHSE:688114
Market cap: CN¥23.1b

Price History & Performance

Summary of share price highs, lows and changes for Tecan Group
Historical stock prices
Current Share PriceCHF 207.40
52 Week HighCHF 211.00
52 Week LowCHF 125.60
Beta1.09
1 Month Change4.96%
3 Month Change29.87%
1 Year Change25.70%
3 Year Changen/a
5 Year Changen/a
Change since IPO22.00%

Recent News & Updates

Recent updates

Shareholder Returns

1TECNIT Life SciencesIT Market
7D-0.9%-4.4%0.0009%
1Y25.7%3.8%19.2%

Return vs Industry: 1TECN exceeded the Italian Life Sciences industry which returned 3.8% over the past year.

Return vs Market: 1TECN exceeded the Italian Market which returned 19.2% over the past year.

Price Volatility

Is 1TECN's price volatile compared to industry and market?
1TECN volatility
1TECN Average Weekly Movement5.6%
Life Sciences Industry Average Movement5.7%
Market Average Movement4.1%
10% most volatile stocks in IT Market7.3%
10% least volatile stocks in IT Market2.6%

Stable Share Price: 1TECN's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: 1TECN's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Italian stocks.

About the Company

FoundedEmployeesCEOWebsite
19803,000Monica Manotaswww.tecan.com

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution.

Tecan Group AG Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
1TECN fundamental statistics
Market cap€2.56b
Earnings (TTM)-€123.21m
Revenue (TTM)€922.20m
2.8x
P/S Ratio
-20.7x
P/E Ratio

Is 1TECN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1TECN income statement (TTM)
RevenueCHF 870.53m
Cost of RevenueCHF 574.03m
Gross ProfitCHF 296.50m
Other ExpensesCHF 412.81m
Earnings-CHF 116.30m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 05, 2026

Earnings per share (EPS)-9.44
Gross Margin34.06%
Net Profit Margin-13.36%
Debt/Equity Ratio13.6%

How did 1TECN perform over the long term?

See historical performance and comparison

Dividends

1.5%
Current Dividend Yield
-32%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 03:46
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tecan Group AG is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harry GillisBerenberg
Delphine Le LouetBernstein
Susannah LudwigBernstein

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide